Major pharmaceutical companies are racing to launch breakthrough drugs to treat advanced melanoma, the deadliest form of skin cancer.
These majors include:
Bristol-Myers Squibb
Roche Holding
Merck
AstraZeneca
I wonder which of these four will be the first in making a call to Cellmid & Co.
The mind boggles when looking at the $'s on offer for a ground breaking new drugs.
The above four are no different to other any other food, engineering or manufacturing businesses; they need new innovative products to grow revenue streams and be a market leader
Well, Midkine can possibly provide that opportunity.
Is this it?
Add AN1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.768M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2852402 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 2617059 | 3 |
View Market Depth
| Last trade - 16.00pm 18/06/2024 (20 minute delay) ? |
|
|||||
|
Last
0.6¢ |
Change
0.000 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 0.6¢ | 0.6¢ | 0.6¢ | 64818 | ||
| Last updated 15.19pm 18/06/2024 ? | |||||
| AN1 (ASX) Chart |
Day chart unavailable